Michael Lowe
@MichaelCLoweMD
Followers
317
Following
48
Statuses
36
Surgical oncologist, melanoma specialist, researcher, husband, father
Atlanta, GA
Joined January 2018
@WinshipAtEmory Join us for an incredible group of speakers to discuss updates in management of melanoma, MCC, SCC, and difficult pigmented lesions @DrSapnaPatel @MarkFariesMD @SuephyC Michael Tetzlaff @UCSFCancer Chris Barker @MSKCancerCenter
0
0
0
@Chrystal_Paulos @WinshipAtEmory @sitcancer Thanks to @gmboland and @sitcancer for the invitation to highlight with @AshleyHolderMD the importance of surgeons in the care of patients with metastatic melanoma @EmorySurgery
0
1
8
Grateful for the tremendous efforts of the study team and our patients (and for the support of great colleagues like @CrisyRoland). What neoadjuvant regimen is the right one?! @WinshipAtEmory
@MichaelCLoweMD @EmorySurgery presenting exciting data evaluating pepinimab +/- nivolumab/ipilimimab in patients with resectable melanoma.
0
2
23
Congratulations @DrSapnaPatel and the S1801 study team on an incredible practice-changing effort @WinshipAtEmory @MDAndersonNews
1
6
54
@LesinskiLab @WinshipAtEmory @EmoryUniversity Come join our collaborative multidisciplinary and translational team of outstanding melanoma scientists and clinicians @zach_buchwald @Chrystal_Paulos.
0
0
4
Excited to join my colleagues @TJH0828 @ragikudchadkar and Scott Albert in a thought provoking discussion.
Sign up for a new virtual tumor board on April 25. @TJH0828, Scott Albert, MD, @MichaelCLoweMD & Ragini Kudchadkar, MD, will have a case-based discussion on evidence supporting neoadjuvant systemic therapy for surgically resectable #melanoma. Register at
1
1
7
@SESC_AmSurg Congrats to @RandiSmithMD for her excellent pitch to the sharks. Privileged to moderate with my Research Committee co- chair Jim McLoughlin on behalf of the committee and the @SESC_AmSurg @EmorySurgery
0
0
1
RT @WinshipAtEmory: Emory investigators will receive a total of $955,000 in funding for new research projects from the Morningside Center f…
0
7
0
Proud to represent @emoryhealthcare @WinshipAtEmory and @EmorySurgery throwing out first pitch @Braves tonight.
6
13
147
RT @ragikudchadkar: Perfect pitch @MichaelCLoweMD! @Braves @WinshipAtEmory @EmoryHealthcare #SunSafety
0
3
0
RT @WinshipAtEmory: Winship and the @Braves have partnered to promote #sunsafety this summer. Winship surgical oncologist @MichaelCLoweMD w…
0
3
0
RT @SocSurgOnc: In the latest episode of SurgOnc Today, Richard White, MD, moderates as Nasreen Vohra, MD, reviews updates on local therapi…
0
2
0
RT @MASC_Trials: Another significant step forward for MelMarT-II, with 23 more participants recruited last month. A fantastic global effort…
0
3
0
RT @WinshipAtEmory: #ASCO21 | Poster Session | Melanoma/Skin Cancers "Winship 4851-19: A pilot study of neoadjuvant and adjuvant cemiplimab…
0
2
0
RT @WinshipAtEmory: #WinshipClinicalTrial UCDCCSO034 | Biomarker Analysis of Neoadjuvant Intralesional Therapy in High-Risk Primary #Melano…
0
1
0
RT @TJH0828: Analysis of Head/Neck Melanoma Rx in post-MSLT 2 era from Dr. Baecher @WinshipAtEmory and colleagues from 21 centers #EADO2021…
0
6
0
Congrats to a great team led by @KristyBroman @jzager99 Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after MSLT‐2
0
1
3